FDC
Quarterly Results Analysis [Dec2023]
FDC Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹458 Cr | ₹486 Cr | ₹536 Cr | ₹435 Cr | ₹409 Cr | ₹445 Cr | ₹495 Cr | ₹341 Cr |
Expenses | ₹374 Cr | ₹410 Cr | ₹414 Cr | ₹386 Cr | ₹360 Cr | ₹378 Cr | ₹417 Cr | ₹322 Cr |
Operating Income | ₹84 Cr | ₹76 Cr | ₹122 Cr | ₹49 Cr | ₹49 Cr | ₹67 Cr | ₹78 Cr | ₹19 Cr |
Other Income | ₹25 Cr | ₹27 Cr | ₹29 Cr | ₹7 Cr | ₹18 Cr | ₹13 Cr | ₹19 Cr | ₹10 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr |
Profit Before Tax | ₹98 Cr | ₹93 Cr | ₹141 Cr | ₹45 Cr | ₹57 Cr | ₹69 Cr | ₹87 Cr | ₹19 Cr |
Profit After Tax | ₹79 Cr | ₹70 Cr | ₹110 Cr | ₹31 Cr | ₹41 Cr | ₹52 Cr | ₹71 Cr | ₹10 Cr |
EPS | ₹4.87 | ₹4.29 | ₹6.62 | ₹1.85 | ₹2.46 | ₹3.12 | ₹4.26 | ₹0.62 |
Industry Peers & Returns | 1W | 1M | 1Y |
FDC | -1.3% | -11% | 71.9% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
FDC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -5.80 % |
Y-o-Y | 11.94 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹458 Cr | -5.80 | |
Sep2023 | ₹486 Cr | -9.32 | |
Jun2023 | ₹536 Cr | 23.36 | |
Mar2023 | ₹435 Cr | 6.23 | |
Dec2022 | ₹409 Cr | -8.02 | |
Sep2022 | ₹445 Cr | -10.04 | |
Jun2022 | ₹495 Cr | 45.04 | |
Mar2022 | ₹341 Cr | - |
FDC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.64 % |
Y-o-Y | 70.19 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹84 Cr | 9.64 | |
Sep2023 | ₹76 Cr | -37.36 | |
Jun2023 | ₹122 Cr | 149.22 | |
Mar2023 | ₹49 Cr | -0.57 | |
Dec2022 | ₹49 Cr | -26.87 | |
Sep2022 | ₹67 Cr | -13.69 | |
Jun2022 | ₹78 Cr | 306.12 | |
Mar2022 | ₹19 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 16.42 % |
Y-o-Y | 52.04 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 18.29% | 16.42 | |
Sep2023 | 15.71% | -30.95 | |
Jun2023 | 22.75% | 102.04 | |
Mar2023 | 11.26% | -6.40 | |
Dec2022 | 12.03% | -20.49 | |
Sep2022 | 15.13% | -4.06 | |
Jun2022 | 15.77% | 180.11 | |
Mar2022 | 5.63% | - |
FDC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 13.45 % |
Y-o-Y | 94.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹79 Cr | 13.45 | |
Sep2023 | ₹70 Cr | -36.45 | |
Jun2023 | ₹110 Cr | 258.14 | |
Mar2023 | ₹31 Cr | -24.68 | |
Dec2022 | ₹41 Cr | -21.40 | |
Sep2022 | ₹52 Cr | -26.70 | |
Jun2022 | ₹71 Cr | 579.82 | |
Mar2022 | ₹10 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 20.42 % |
Y-o-Y | 73.67 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 17.28 % | 20.42 | |
Sep2023 | 14.35 % | -29.90 | |
Jun2023 | 20.47 % | 190.35 | |
Mar2023 | 7.05 % | -29.15 | |
Dec2022 | 9.95 % | -14.52 | |
Sep2022 | 11.64 % | -18.49 | |
Jun2022 | 14.28 % | 368.20 | |
Mar2022 | 3.05 % | - |
FDC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 13.52 % |
Y-o-Y | 97.97 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹4.87 | 13.52 | |
Sep2023 | ₹4.29 | -35.20 | |
Jun2023 | ₹6.62 | 257.84 | |
Mar2023 | ₹1.85 | -24.80 | |
Dec2022 | ₹2.46 | -21.15 | |
Sep2022 | ₹3.12 | -26.76 | |
Jun2022 | ₹4.26 | 587.10 | |
Mar2022 | ₹0.62 | - |
You may also like the below Video Courses